“The blockbuster weight loss drug Wegovy is now approved to reduce heart disease risk, drugmaker Novo Nordisk said Friday…

The change comes after, in a late-stage clinical trial of more than 17,000 adults, Novo Nordisk found that Wegovy cut the risk of cardiovascular events — such as heart attack and stroke — by 20% compared to a placebo.”

From NBC News.